Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant

Bone Marrow Transplantation

Volumn 22, Issue 5, 1998, Pages 507-509

  Seropian, S ^a   Ferguson, D ^b   Salloum, E ^a   Cooper, D ^a   Landry, M L ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

BMT; CMV infection; CMV pp65 antigenemia

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD CULTURE; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 0031666556     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701354     Document Type: Article

References (11)

1. van der Bij W, Torensma R, van Son WJ et al. Rapid immunodiagnosis of active cytomesalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 1988; 25: 179-188.
2. van der Bij W, Schirm J, Torensma R et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988; 26: 2531-2535.
3. Boeckh M, Bowden RA, Goodrich JM et al. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358-1364.
4. Goodrich JM, Mori M, Gleaves CA et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. New Engl J Med 1991; 325: 1601-1607.
5. Schmidt GM, Horak DA, Niland JC et al. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants: The City of Hope-Stantbrd-Syntex CMV Study Group. New Engl J Med 1991; 324: 1005-1011.
6. Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol 1993; 31: 2851-2856.
7. Herrmann J. Immunoassays for the diagnosis of infectious diseases. In: Murray P, Baron E, Pfaller M et al (eds). Manual of Clinical Microbiology, ASM Press: Washington DC, 1995, pp 110-122.
8. St George K, Rinaldo CR Jr. Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay. Clin Diagn Virol 1997; 7: 147-152.
9. Gerna G, Revello M, Percivalle E et al. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30: 1232-1237.
10. St George K, Boyd M, Lipson S et al. A multi-site trial comparing two commercially available kits for CMV antigenemia testing, Clinical Virology Symposium, Clearwater Beach, FL, April 26-29, 1998.
11. Rees G, Sarmiento J, Myerson D et al. Cytomegalovirus hepatitis in marrow transplant patients: clinical, histologic and histochemical analysis. Gastroenterology 1989; 98: A470.